Baidu
map

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study

Brown, ML; Motsch, J; Kaye, KS; File, TM; Boucher, HW; Vendetti, N; Aggrey, A; Joeng, HK; Tipping, RW; Du, JJ; DePestel, DD; Butterton, JR; Paschke, A

Paschke, A (corresponding author), Merck & Co Inc, 2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA.

OPEN FORUM INFECTIOUS DISEASES, 2020; 7 (3):

Abstract

Background. In the randomized controlled RESTORE-IMI 1 clinical trial (NCT02452047), imipenem/cilastatin (IMI) with relebactam (IMI/REL) was as effect......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

Baidu
map
Baidu
map
Baidu
map